Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
A post-doctoral research position is available in the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center. We are seeking a recent or prospective doctoral graduate (Ph.D. or equivalent qualification) with a background molecular and genetic cancer epidemiology or related subject areas. This could include, but is not limited to, training in epidemiology, quantitative genetics, statistical genetics, or a closely related field (please note that this is NOT a laboratory-based position). The postdoctoral fellow/research associate will work directly with Dr. Polly Newcomb and another investigator in Public Health Sciences on analyzing data from large-scale molecular epidemiological studies for cancer. Data analyses could include working with targeted tumor sequencing data, germline GWAS data, and harmonized epidemiologic and clinical outcomes data in well characterized cancer cases and controls from sizeable studies.
The postdoctoral candidate will primarily work on integrative tumor analyses. The successful applicant will work on multidisciplinary research teams to perform data analyses, develop and/or implement novel statistical methodology, incorporate functional genetic information, and publish research results. The incumbent will be expected to work independently to complete data analysis. In addition, they will participate in the presentation of research, as well as in the writing of publications to disseminate the analyses.
A Ph.D. or equivalent degree is required. The position requires a highly motivated individual with excellent written and verbal communication skills in English. Expertise in computational methods for the analysis of complex, high-dimensional genotype data is desirable, as are experience using high-performance computing and a thorough knowledge of high dimensional data resources (such as ENCODE and ROADMAP) for functional annotations.
Please note that due to funding requirements, a qualified candidate must be a US citizen orpermanent resident.
We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.